Abstract:BACKGROUND: Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The aim of this study was to investigate outcomes in patients with left main disease with and without diabetes undergoing PCI versus CABG. METHODS: Individual patient data were pooled from 4 trials (SYNTAX [TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries], PRECOMBAT [Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease], NOBLE [PCI vs. CABG in the Treatment of Unprotected Left Main Stenosis], and EXCEL [Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization]) that randomized patients with left main disease to PCI or CABG. Patients were considered suitable for either approach. Patients were categorized by diabetes status. Kaplan-Meier event rates, Cox model hazard ratios, and interactions were assessed. RESULTS: Among 4393 patients, 1104 (25.1%) had diabetes. Patients with diabetes experienced higher rates of 5-year death (158/1104 [Kaplan-Meier rate, 14.7%] versus 297/3289 [9.3%]; P <0.001), spontaneous myocardial infarction (MI; 67/1104 [6.7%] versus 114/3289 [3.7%]; P <0.001), and repeat revascularization (189/1104 [18.5%] versus 410/3289 [13.2%]; P <0.001). Rates of all-cause mortality did not differ after PCI versus CABG in those with (84/563 [15.3%] versus 74/541 [14.1%]; hazard ratio, 1.11 [95% CI, 0.82–1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86–1.36; P intHR =0.87) diabetes. Rates of stroke within 1 year were lower with PCI versus CABG in the entire population, with no heterogeneity based on diabetes status ( P intHR =0.51). The 5-year rates of spontaneous MI and repeat coronary revascularization were higher after PCI regardless of diabetes status (spontaneous MI: 45/563 [8.9%] versus 22/541 [4.4%] in diabetes and 82/1634 [5.3%] versus 32/1655 [2.1%] in no diabetes, P intHR =0.47; repeat revascularization: 127/563 [24.5%] versus 62/541 [12.4%] in diabetes and 254/1634 [16.3%] versus 156/1655 [10.1%] in no diabetes, P intHR =0.18). For spontaneous MI and repeat revascularization, there were greater absolute excess risks beyond 1 year in patients with diabetes (4.9% and 9.9%) compared with those without (2.1% and 4.3%; P intARD =0.047 and 0.016). CONCLUSIONS: In patients with left main disease considered equally suitable for PCI or CABG and with largely low to intermediate SYNTAX scores, diabetes was associated with higher rates of death and cardiovascular events through 5 years. Compared with CABG, PCI resulted in no difference in the risk of death, a lower risk of early stroke regardless of diabetes status, and a higher risk of spontaneous MI and repeat coronary revascularization, with larger late absolute excess risks in patients with diabetes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT01205776, NCT0146651, NCT00422968, and NCT00114972

The Effects of Insulin Therapy on Mortality in Diabetic Patients Undergoing Percutaneous Coronary Intervention

Impact of Hyperinsulinemia on Long-Term Clinical Outcomes of Percutaneous Coronary Intervention in Patients Without Diabetes Who Have Acute Myocardial Syndrome.

Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.

Postoperative Short-Term Mortality Between Insulin-Treated and Non-Insulin-treated Patients with Diabetes after Non-Cardiac Surgery: a Systematic Review and Meta-Analysis

Effects on All-Cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-Analysis of Randomized Controlled Trials.

Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention

Influence of insulin resistance on long-term outcomes in patients.

Comparing Mortality and Myocardial Infarction Between Coronary Artery Bypass Grafting and Drug-Eluting Stenting in Patients with Diabetes Mellitus and Multivessel Coronary Artery Disease: a Meta-Analysis

[Effect of Intensive Insulin Therapy on Prognosis in Patients With Acute Myocardial Infarction].

[Long-Term Outcomes and Risk Factors of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery after Percutaneous Coronary Intervention].

The impact of prognosis after intensive insulin therapy in non-diabetic patients of old ages on CABG with cardiopulmonary bypass

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

Ten-year All-Cause Death after Percutaneous or Surgical Revascularization in Diabetic Patients with Complex Coronary Artery Disease

Effects of insulin resistance with homeostasis model assessment on short-term prognosis of non-diabetic patients with ST-segment elevation myocardial infarction

Treatment Outcomes of Clopidogrel in Patients with ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database.

Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention

Long-term outcomes after stent implantation in patients with coronary atherosclerotic heart disease and diabetes mellitus

Impact of insulin therapy to control blood glucose on different levels on criticaly ill patients

Influence of diabetes on mortality and ICD therapies in ICD recipients: a systematic review and meta-analysis of 162,780 patients

[Impact of Insulin Resistance on Prognosis in Non-Diabetic Patients with Acute Coronary Syndromes].